| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancements in manganese complex-based MRI agents: Innovations, design strategies, and future directions
|
Roy, Shubham
|
|
|
29 |
9 |
p.
|
artikel
|
| 2 |
Advances in structure-based drug design targeting membrane protein markers in prostate cancer
|
Batista-Silva, João P.
|
|
|
29 |
9 |
p.
|
artikel
|
| 3 |
Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
|
Cordeiro, Ana
|
|
|
29 |
9 |
p.
|
artikel
|
| 4 |
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2
|
Lucaj, Tom
|
|
|
29 |
9 |
p.
|
artikel
|
| 5 |
Caught between a ROCK and a hard place: current challenges in structure-based drug design
|
Pala, Daniele
|
|
|
29 |
9 |
p.
|
artikel
|
| 6 |
Clinical trial evidence supporting FDA approval of novel orphan drugs between 2017 and 2023
|
Chen, Qi
|
|
|
29 |
9 |
p.
|
artikel
|
| 7 |
Comparative analysis of FDA approvals by top 20 pharma companies (2014–2023)
|
Schuhmacher, Alexander
|
|
|
29 |
9 |
p.
|
artikel
|
| 8 |
Current understanding of the link between angiotensin-converting enzyme and pain perception
|
Bhilare, Kiran D.
|
|
|
29 |
9 |
p.
|
artikel
|
| 9 |
Deciphering immune responses: a comparative analysis of influenza vaccination platforms
|
Jones, Charles H.
|
|
|
29 |
9 |
p.
|
artikel
|
| 10 |
Developing public–private R&D consortia to accelerate Alzheimer’s disease drug development
|
West, Joel
|
|
|
29 |
9 |
p.
|
artikel
|
| 11 |
Ionic liquid-based formulation approaches for enhanced transmucosal drug delivery
|
Khan, Omar
|
|
|
29 |
9 |
p.
|
artikel
|
| 12 |
Metallocompounds as anticancer agents against osteosarcoma
|
Santa Maria de la Parra, Lucía
|
|
|
29 |
9 |
p.
|
artikel
|
| 13 |
Multidisciplinary considerations for implementing Bayesian borrowing in basket trials
|
Broglio, Kristine R.
|
|
|
29 |
9 |
p.
|
artikel
|
| 14 |
Navigating the frontier of drug-like chemical space with cutting-edge generative AI models
|
Lavecchia, Antonio
|
|
|
29 |
9 |
p.
|
artikel
|
| 15 |
Navigating the future of health care with AI-driven digital therapeutics
|
Vasdev, Nupur
|
|
|
29 |
9 |
p.
|
artikel
|
| 16 |
Neurological insights into brain-targeted cancer therapy and bioinspired microrobots
|
Ghosh, Shampa
|
|
|
29 |
9 |
p.
|
artikel
|
| 17 |
New developments in celiac disease treatments
|
Buriánek, Franziska
|
|
|
29 |
9 |
p.
|
artikel
|
| 18 |
Oxygen-generating biomaterials for cardiovascular engineering: unveiling future discoveries
|
Mozafari, Masoud
|
|
|
29 |
9 |
p.
|
artikel
|
| 19 |
P-glycoprotein inhibitors as an adjunct therapy for TB
|
Parida, Kishan Kumar
|
|
|
29 |
9 |
p.
|
artikel
|
| 20 |
Phytochemicals in antiviral drug development against human respiratory viruses
|
Mehta, Surya Kant
|
|
|
29 |
9 |
p.
|
artikel
|
| 21 |
Reliable business case for repurposing of existing medicines requires key changes in government policies
|
de Visser, Samuel J.
|
|
|
29 |
9 |
p.
|
artikel
|
| 22 |
Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world
|
Jones, Charles H.
|
|
|
29 |
9 |
p.
|
artikel
|
| 23 |
Synergizing blockchain and artificial intelligence to enhance healthcare
|
Omidian, Hossein
|
|
|
29 |
9 |
p.
|
artikel
|
| 24 |
Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design
|
Shivani,
|
|
|
29 |
9 |
p.
|
artikel
|
| 25 |
Targeting histone deacetylases: Emerging applications beyond cancer
|
Raouf, Yasir S.
|
|
|
29 |
9 |
p.
|
artikel
|
| 26 |
The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms
|
Bouwman, Hendrikus Bernhard
|
|
|
29 |
9 |
p.
|
artikel
|
| 27 |
Therapies for Inherited Retinal Dystrophies: What is Enough?
|
Leroy, Bart P.
|
|
|
29 |
9 |
p.
|
artikel
|
| 28 |
Three-dimensional cell culture: Future scope in cancer vaccine development
|
Rahman, Mahfoozur
|
|
|
29 |
9 |
p.
|
artikel
|
Tijdschrift beschrijving